◀ Back to IRF6

ICOSLG — IRF6

Text-mined interactions from Literome

Taylor et al., Blood 2005 (Graft vs Host Disease) : ICOS ligand , a B7 family member, is constitutively expressed on B cells, macrophages, and dendritic cells and is up-regulated on antigen presenting cells (APCs) and some nonlymphoid tissues by tumor necrosis factor alpha (TNFalpha) or lipopolysaccharide (LPS)
Zhou et al., Eur J Immunol 2005 : In this report, we demonstrate that LPS induced up-regulation of B7-related protein 1 (B7RP-1) , a ligand for ICOS, is dependent primarily upon the MyD88 dependent signaling pathway ... Hence, LPS induces significantly higher B7RP-1 expression on TRIF- or TRAM-deficient mouse peritoneal macrophages and on TRIF-deficient mouse splenic B cells as compared to wild-type cells
Thoeni et al., J Immunol 2005 : Checking for a possible influence on LPS induced dendritic cell maturation, we found that tetrahydro-4-aminobiopterin down-regulated MHC class II expression and counteracted LPS induced down-regulation of ICOS ligand , while expression of CD40, CD86, CD80, B7-H1, and B7-DC remained unchanged